Bruce E Wexler, MD

Digital Neurotherapy: Helped launch the field with studies published in 1997, 2000.

Brain and Culture (MIT Press 2006) seminal text in cultural neuroscience (new edition forthcoming).

NIH Director's Award for high impact, high innovation, paradigm changing medical research, supporting development of digital neurotherapy 2012-2016.

Founder and President "A Different Future", an NGO to reclaim the public idea space from extremists regarding the Israeli-Palestinian conflict 2002-14 (co-founders Ambassador Andrew Young and Rabbi Alvin Sugarman); Facilitator for the Council of Religious Institutions of the Holy Land, conducted U.S. State Department funded study of how "the other" is portrayed in Israeli and Palestinian school books 2007-13 (convener Rev Trond Bakkevig) .

Founder and Chief Scientist, C8 Sciences 2011- present, harnessing neuroplasticity in technology-enhanced content-independent micro-cognition training and assessment programs to directly improve thinking abilities and close academic achievement gaps in 5-9 year old children, provide scalable, non-invasive micro-cognition biomarkers to transform psychiatric diagnosis and create novel digital neurotherapies that improve outcomes in ADHD, Depression, Schizophrenia and Mild Cognitive Impairment.

Founder and Chief Scientist, Neutargeton Therapeutics 2023- present, non-invasive digital activation of nano-carrier technology to deliver CNS drugs to where they are needed in the brain and increase on-target treatment effects and decrease off-target side effects. Patent approved in <85 days because of absence of any prior art